Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation.

Saved in:
Bibliographic Details
Title: Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation.
Authors: Eiamprapaporn P; Department of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand., Venegas Mata C; Department of Pharmaceutical Sciences, South Dakota State University, Brookings, SD 57007, USA., Nandani R; Department of Immunology, Mayo Clinic, Jacksonville, FL 32224, USA.; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA., Susiriwatananont T; Department of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand., Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, FL 32224, USA.; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA., Chumsri S; Department of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA.
Source: Cancers [Cancers (Basel)] 2026 May 13; Vol. 18 (10). Date of Electronic Publication: 2026 May 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers18101588